These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22156250)

  • 1. Preparation and evaluation of a chrysotile asbestos-containing standard material for validating x-ray diffractometric quantitation.
    Asahi T; Kobayashi S; Nakayama K; Konya T; Fujinawa G; Nakamura T
    Anal Sci; 2011; 27(12):1217-21. PubMed ID: 22156250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of purity of chrysotile asbestos by X-ray diffractometry/Rietveld refinement.
    Asahi T; Matsudaira T; Kobayashi S; Nakayama K; Nakamura T
    Anal Sci; 2010; 26(12):1295-300. PubMed ID: 21157100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The problem of determining asbestos in bulk materials: a study of the effect of grinding on the diffractometric response of the chrysotile content in an asbestos cement sample].
    Puledda S; Paoletti L
    Med Lav; 1993; 84(4):297-305. PubMed ID: 8255261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of amphibole asbestos in chrysotile and other minerals.
    Addison J; Davies LS
    Ann Occup Hyg; 1990 Apr; 34(2):159-75. PubMed ID: 2169219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrothermal conversion of chrysotile asbestos using near supercritical conditions.
    Anastasiadou K; Axiotis D; Gidarakos E
    J Hazard Mater; 2010 Jul; 179(1-3):926-32. PubMed ID: 20427128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphibole fibres in Chinese chrysotile asbestos.
    Tossavainen A; Kotilainen M; Takahashi K; Pan G; Vanhala E
    Ann Occup Hyg; 2001 Mar; 45(2):145-52. PubMed ID: 11182428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and quantitation of asbestos in talc.
    Rohl AN; Langer AM
    Environ Health Perspect; 1974 Dec; 9():95-109. PubMed ID: 4470959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray powder diffractometric method for quantitation of crystalline drug in microparticulate systems. I. Microspheres.
    Dash AK; Khin-Khin A; Suryanarayanan R
    J Pharm Sci; 2002 Apr; 91(4):983-90. PubMed ID: 11948537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineral phases and some reexamined characteristics of the International Union Against Cancer standard asbestos samples.
    Kohyama N; Shinohara Y; Suzuki Y
    Am J Ind Med; 1996 Nov; 30(5):515-28. PubMed ID: 8909601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in chrysotile in vivo].
    Höhr D; Friedrichs KH
    Zentralbl Bakteriol Mikrobiol Hyg B; 1982 Aug; 176(4):354-67. PubMed ID: 6293222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chamber for testing asbestos-containing products: validation and testing of a re-created chrysotile-containing joint compound.
    Sheehan PJ; Brorby GP; Berman DW; Bogen KT; Holm SE
    Ann Occup Hyg; 2011 Aug; 55(7):797-809. PubMed ID: 21795244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New detoxification processes for asbestos fibers in the environment.
    Turci F; Colonna M; Tomatis M; Mantegna S; Cravotto G; Fubini B
    J Toxicol Environ Health A; 2010; 73(5):368-77. PubMed ID: 20155579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural information in diffuse diffraction patterns.
    Konnert JH
    Environ Health Perspect; 1974 Dec; 9():137-8. PubMed ID: 4470926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of low levels of free fibres of chrysotile in contaminated soils by X-ray diffraction and FTIR spectroscopy.
    Foresti E; Gazzano M; Gualtieri AF; Lesci IG; Lunelli B; Pecchini G; Renna E; Roveri N
    Anal Bioanal Chem; 2003 Jul; 376(5):653-8. PubMed ID: 12802568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Refinement of the methods of diffractometric analysis in relation to the preparation surface exposed to X rays].
    Maddalon G; Occella E; Trimarchi R
    Med Lav; 1989; 80(1):78-89. PubMed ID: 2755386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ ESEM study of the thermal decomposition of chrysotile asbestos in view of safe recycling of the transformation product.
    Gualtieri AF; Gualtieri ML; Tonelli M
    J Hazard Mater; 2008 Aug; 156(1-3):260-6. PubMed ID: 18234421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [First intercalibration test of diffractometric measurements of asbestos in National Italian laboratories].
    Puledda S; Ferdinandi M; Plescia P
    Med Lav; 1998; 89(4):292-300. PubMed ID: 9847531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROS-mediated genotoxicity of asbestos-cement in mammalian lung cells in vitro.
    Dopp E; Yadav S; Ansari FA; Bhattacharya K; von Recklinghausen U; Rauen U; Rödelsperger K; Shokouhi B; Geh S; Rahman Q
    Part Fibre Toxicol; 2005 Oct; 2():9. PubMed ID: 16209709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On-site detection of asbestos at the surface of building materials wasted at disaster sites by staining.
    Tabata M; Fukuyama M; Yada M; Toshimitsu F
    Waste Manag; 2022 Feb; 138():180-188. PubMed ID: 34896738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.